Key result
Review outlines current and future non-biopsy and immune-based diagnostic approaches for coeliac disease.
Why the study?
Diagnostics play a central role in addressing the dramatic rise in coeliac disease prevalence and deploying new non-dietary therapeutics.
Highlights current consensus and future potential for non-biopsy and immunity-based diagnostics in coeliac disease.
Supports non-biopsy diagnostics amid rising coeliac prevalence; leaves open prospective validation of gluten-specific immunity assays.
Diagnostics will play a central role in addressing the ongoing dramatic rise in global prevalence of coeliac disease, and in deploying new non-dietary therapeutics. Clearer understanding of the immunopathogenesis of coeliac disease and the utility of serology has led to partial acceptance of non-biopsy diagnosis in selected cases. Non-biopsy diagnosis may expand further because research methods for measuring gluten-specific CD4+ T cells and the acute recall response to gluten ingestion in patients is now relatively straightforward. This perspective on diagnosis in the context of the immunopathogenesis of coeliac disease sets out to highlight current consensus, limitations of current practices, gluten food challenge for diagnosis and the potential for diagnostics that measure the underlying cause for coeliac disease, gluten-specific immunity.
No takes yet. Share an insight, caveat, or question.
Robert P. Anderson (2022) conducted a review in coeliac disease. Diagnostics for coeliac disease was evaluated. Current and future diagnostic approaches for coeliac disease, including non-biopsy methods and measurement of gluten-specific immunity, are reviewed to address the rising global prevalence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: